Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A - C-Raf. (2019)

First Author: Blair CM
Attributed to:  Glasgow Precision Diagnostics and Therapeutics (P2D 2017) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12885-019-5489-4

PubMed Identifier: 30909892

Publication URI: http://europepmc.org/abstract/MED/30909892

Type: Journal Article/Review

Volume: 19

Parent Publication: BMC cancer

Issue: 1

ISSN: 1471-2407